Standout Papers
Citation Impact
Citing Papers
The IASP classification of chronic pain for ICD-11: chronic primary pain
2018 Standout
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
2009 Standout
Functional bowel disorders and functional abdominal pain
1999 Standout
Principles of applied neurogastroenterology: physiology/motility–sensation
1999
A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome
2009
New treatments for IBS
2012
Prevalence and Characteristics of Irritable Bowel Syndrome Among Women With Chronic Pelvic Pain
2004
Health-related quality of life and associated psychosocial factors in irritable bowel syndrome: A review
2000
Irritable bowel syndrome in a Bangladeshi urban community: Prevalence and health care seeking pattern
2009
Functional Bowel Disorders
2006 Standout
Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome
2004
Prevalence and Risk Factors of Irritable Bowel Syndrome in Asia
2010
Prokinetic effects in patients with intestinal gas retention
2002
Gastrointestinal dysfunction in Parkinson's disease
2003 Standout
Functional Gastroduodenal Disorders
2006 Standout
Human brain mechanisms of pain perception and regulation in health and disease
2005 Standout
Evidence- and Consensus-Based Practice Guidelines for the Diagnosis of Irritable Bowel Syndrome
2001
A population‐based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling
2004
The impact of irritable bowel syndrome on health-related quality of life
2000 Standout
Bowel Disorders
2016 Standout
Molecular, pharmacological and functional diversity of 5-HT receptors
2002 Standout
Psychosocial Aspects of the Functional Gastrointestinal Disorders
2006
Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome
2004
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Management of the irritable bowel syndrome
2001
Prevalence and Impact of Upper and Lower Gastrointestinal Symptoms in the Greek Urban General Population
2005
Sex differences in irritable bowel syndrome in Japanese university students
2006
Antidepressant Therapy (Imipramine and Citalopram) for Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled Trial
2007
Serotonin and Its Role in Colonic Function and in Gastrointestinal Disorders
2006
Irritable Bowel Syndrome: Epidemiology, Natural History, Health Care Seeking and Emerging Risk Factors
2005
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
2008 Standout
The Oslo definitions for coeliac disease and related terms
2012 Standout
Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome
2001
Irritable bowel syndrome in general practice: prevalence, characteristics, and referral
2000 Standout
The Irritable Bowel Syndrome and Psychiatric Disorders in The Community: Is There A Link?
2001
A Dose-Ranging, Phase II Study of the Efficacy and Safety of Alosetron in Men with Diarrhea-Predominant IBS
2005
Predictors of Health Care Seeking for Irritable Bowel Syndrome and Nonulcer Dyspepsia: A Critical Review of the Literature on Symptom and Psychosocial Factors
2001
An international urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction
2009 Standout
Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire
2000
Criterion-Related Validity of the Diagnostic Criteria for Psychosomatic Research for Alexithymia in Patients with Functional Gastrointestinal Disorders
2001
Paroxetine to Treat Irritable Bowel Syndrome Not Responding to High-Fiber Diet: A Double-Blind, Placebo-Controlled Trial
2004
Recurrent abdominal pain in children
2002
Chronic narcotic use in inflammatory bowel disease patients: Prevalence and clinical characteristics
2001
The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome
2000
The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders
2007 Standout
ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease
2013 Standout
Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial
2000 Standout
Celiac Disease
2007 Standout
Postnatal microbial colonization programs the hypothalamic–pituitary–adrenal system for stress response in mice
2004 Standout
Irritable bowel syndrome
2016 Standout
Irritable Bowel Syndrome in Patients with Blastocystis hominis Infection
1999
Intergenerational Transmission of Gastrointestinal Illness Behavior
2000
Functional Gut Disorders
1998
Dyspeptic symptoms and gastric emptying in the irritable bowel syndrome
2002
Confocal Endomicroscopy Shows Food-Associated Changes in the Intestinal Mucosa of Patients With Irritable Bowel Syndrome
2014
New insights into the psychosocial aspects of irritable bowel syndrome
2003
Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non‐selected adult population
2004
Serotoninergic neuroenteric modulators
2001
What determines severity among patients with painful functional bowel disorders?
2000
Sex, Gender, and Pain: A Review of Recent Clinical and Experimental Findings
2009 Standout
The Functional Gastrointestinal Disorders and the Rome III Process
2006 Standout
A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome
2013 Standout
Irritable Bowel Syndrome
2001
Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications?
2002 Standout
The functional gastrointestinal disorders and the Rome II process
1999
NK1 receptor-mediated mechanisms regulate colonic hypersensitivity in the guinea pig
2003
Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders
2001 Standout
Irritable bowel syndrome in France
2004
The economic impact of irritable bowel syndrome
2003
Treatment of irritable bowel syndrome with herbal preparations: results of a double‐blind, randomized, placebo‐controlled, multi‐centre trial
2004
Serotonergic modulation of visceral sensation: lower gut
2002
The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
2014 Standout
Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care
2001
Frequency of Functional Bowel Disorders among Healthy Volunteers in Mexico City
2006
High-Fiber Diet Supplementation in Patients with Irritable Bowel Syndrome (IBS): A Multicenter, Randomized, Open Trial Comparison Between Wheat Bran Diet and Partially Hydrolyzed Guar Gum (PHGG)
2002
Gastrointestinal Illness and the Biopsychosocial Model
1998
The 20-Item Toronto Alexithymia Scale
2003 Standout
Tegaserod
2001
Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome as Well as Traditional Dietary Advice: A Randomized Controlled Trial
2015 Standout
Insights into the Pathophysiology and Mechanisms of Constipation, Irritable Bowel Syndrome, and Diverticulosis in Older People
2000
Cognitive-Behavioral Group Therapy for Patients with Irritable Bowel Syndrome
1998
Is a negative colonoscopy associated with reassurance or improved health-related quality of life in irritable bowel syndrome?
2005
The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review
2002
Celiac disease and irritable bowel-type symptoms
2002
3 Is functional dyspepsia just a subset of the irritable bowel syndrome?
1998
An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome
2003
Brain Responses To Visceral and Somatic Stimuli in Patients With Irritable Bowel Syndrome With and Without Fibromyalgia
2003
Psychosocial aspects of the functional gastrointestinal disorders
1999
Costs of Irritable Bowel Syndrome in the UK and US
2006
Ulcerative colitis
2020 Standout
Childhood Functional Gastrointestinal Disorders: Child/Adolescent
2006 Standout
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
Increased Prevalence of Sicca Complex and Fibromyalgia in Patients With Irritable Bowel Syndrome
1999
Gender differences in irritable bowel syndrome
2002
Rectal distention testing in patients with irritable bowel syndrome: Sensitivity, specificity, and predictive values of pain sensory thresholds
2002
Do psychosocial factors define symptom severity and patient status in irritable bowel syndrome?
1999
Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials
2001
Long-term sensitization of primary afferents in adult rats exposed to neonatal colon pain
2003
AGA technical review on irritable bowel syndrome
2002 Standout
Meta‐analysis: the treatment of irritable bowel syndrome
2004
Review article: an integrated approach to the irritable bowel syndrome
1999
High Prevalence of Irritable Bowel Syndrome in Medical Outpatients in Japan
2008
Anorectal function in multiple system atrophy and Parkinson's disease
2000
Quality of Life in Persons with Irritable Bowel Syndrome (Development and Validation of a New Measure)
1998 Standout
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
2012 Standout
Predictive Value of The Rome Criteria for Diagnosing The Irritable Bowel Syndrome
1999
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis
2008 Standout
Management of Crohn's Disease in Adults
2009 Standout
Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease
2002
Effect of tegaserod on gut transit in male and female subjects
2005
The Intestinal Microbiota Affect Central Levels of Brain-Derived Neurotropic Factor and Behavior in Mice
2011 Standout
The epidemiology of irritable bowel syndrome in North America: a systematic review1
2002
Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome
2002
Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double‐blind, placebo‐controlled, dose‐ranging study to evaluate efficacy and safety
2007
Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome
2001
Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cereals
2011
Health‐related quality of life among persons with irritable bowel syndrome: a systematic review
2002
Systematic review and meta‐analysis: the incidence and prognosis of post‐infectious irritable bowel syndrome
2007
Hypnotherapy for treatment of irritable bowel syndrome
2007
Irritable Bowel Syndrome and Health-Related Quality of Life: A Population-Based Study in Calgary, Alberta
2003
Irritable Bowel Syndrome
2015 Standout
The Complex Role of Estrogens in Inflammation
2007 Standout
Gut Microbiota in Health and Disease
2010 Standout
New Insights on Classification, Identification, and Clinical Relevance ofBlastocystisspp
2008 Standout
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5‐HT3 receptor antagonist
1999
Sex Differences of Brain Serotonin Synthesis in Patients with Irritable Bowel Syndrome Using α-[11C]methyl-L-tryptophan, Positron Emission Tomography and Statistical Parametric Mapping
2003
Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients
1999
Pharmacologic Treatment of the Irritable Bowel Syndrome
2000
Global Epidemiology of Campylobacter Infection
2015 Standout
Intergenerational transmission of gastrointestinal illness behavior
2000
The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: A double blind, randomized, placebo-controlled study
2003
Prevalence of irritable bowel syndrome in the French population according to the Rome I criteria.
2002
Fiber and Prebiotics: Mechanisms and Health Benefits
2013 Standout
Randomized Controlled Trial of Cognitive–Behavioral Group Therapy for Irritable Bowel Syndrome in a Medical Setting
2003
A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development
2000
Irritable bowel syndrome: How far do you go in the workup?
2001
A double‐blind, randomized, placebo‐controlled dose‐ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome
2000
Blastocystis hominis infection in irritable bowel syndrome patients.
2004
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
2016 Standout
Works of WE Whitehead being referenced
Irritable bowel syndrome: A technical review for practice guideline development
1997 Standout
Irritable bowel syndrome : Definition of the syndrome and relation to other disorders. Physiological and psychological mechanism
1985
Functional anorectal disorders.
1996